Pharvaris Nv (PHVS)

03:15 AM

Pharvaris: Deucrictibant Advanced To Target Two Sets Of HAE Patient Populations (PHVS) - Seeking Alpha

03:15 AM

11:50 AM

Pharvaris shares slide following $175 million equity offering - MSN

11:50 AM

11:48 AM

What drives Pharvaris N.V. stock priceHigh-yield capital appreciation - jammulinksnews.com

11:48 AM

09:25 AM

Pharvaris stock drops after pricing $175 million public offering By Investing.com - Investing.com Nigeria

09:25 AM

03:09 AM

What analysts say about Pharvaris N.V. stockOutstanding growth strategies - Autocar Professional

03:09 AM

02:50 AM

Pharvaris' $175M Equity Raise: A Strategic Catalyst for HAE Market Leadership - AInvest

02:50 AM

Jul 22, 2025

Pharvaris' $175M Equity Raise: Fueling a Strategic Leap in the HAE Market - AInvest

Jul 22, 2025

Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs By Investing.com - Investing.com India

Jul 22, 2025

Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times

Jul 22, 2025

Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs - Investing.com

Jul 22, 2025

Jul 22, 2025

Pharvaris Secures Massive $175M Public Offering to Advance Oral HAE Treatment Pipeline - Stock Titan

Jul 22, 2025

Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewswire Inc.

Jul 22, 2025

Jul 22, 2025

Pharvaris N.V. Stock Analysis and ForecastExponential return rates - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Pharvaris' $150M Share Offering: Balancing Dilution Risk and HAE Market Capture in a High-Margin Niche - AInvest

Jul 22, 2025

Jul 22, 2025

IKNA issues special CVR dividend ahead of Inmagene merger | PHVS SEC FilingForm 424B5 - Stock Titan

Jul 22, 2025

Jul 22, 2025

Pharvaris announces $150M ordinary shares offering - TipRanks

Jul 22, 2025

Jul 22, 2025

Pharvaris Announces Proposed Public Offering of Ordinary Shares - The Manila Times

Jul 22, 2025

Jul 22, 2025

Pharvaris Seeks $150M in Public Offering: Major Push for Late-Stage HAE Drug Development - Stock Titan

Jul 22, 2025

Jul 21, 2025

Understanding Stock Volatility in the Indian Market AI Driven Stock AlertsFree Risk Assessment Services - Autocar Professional

Jul 21, 2025

Jul 20, 2025

Is Pharvaris N.V. a good long term investmentExceptional return forecasts - jammulinksnews.com

Jul 20, 2025

Jul 20, 2025

Property Share Investment Trust (544295) Hits 52 Week HighRapid wealth creation - Autocar Professional

Jul 20, 2025

Jul 20, 2025

What drives PTON stock priceBreakout stock performance - jammulinksnews.com

Jul 20, 2025

Jul 19, 2025

What drives iShares Gold Trust stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

NSE Quality Stocks Smart Investor Club PicksHigh-velocity gains - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

Best Renewable Stocks Smart Money Stock PicksPowerful growth strategies - jammulinksnews.com

Jul 18, 2025

Jul 18, 2025

What risks could impact Pharvaris N.V. stock performanceHigh Return Stock Alerts - Newser

Jul 18, 2025

Jul 18, 2025

Pharvaris: More Convenience, More Potency, And More Potential For Future HAE Success - Seeking Alpha

Jul 18, 2025

Jul 17, 2025

How To Trade (PHVS) - news.stocktradersdaily.com

Jul 17, 2025

Jul 16, 2025

Why Pharvaris N.V. stock attracts strong analyst attentionGrowth Optimized Stock Radar - beatles.ru

Jul 16, 2025

Jul 15, 2025

How Pharvaris N.V. stock performs during market volatilityFree Investment Community - Newser

Jul 15, 2025

Jul 15, 2025

What makes Pharvaris N.V. stock price move sharplyReal Time Alert Service - Newser

Jul 15, 2025

Jul 14, 2025

Pharvaris (NASDAQ:PHVS) Reaches New 1-Year High – Should You Buy? - Defense World

Jul 14, 2025

Jul 11, 2025

Pharvaris N.V. shares fall 4.98% in after-hours after updating key study data release timeline to Q4 2025. - AInvest

Jul 11, 2025